Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23
Phase 32

Trial Status

Completed3
Recruiting1
Other1

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT06066203Phase 1/2Recruiting
A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies
Non-hodgkin's Lymphoma
PrincipalinvestigatorStart date: 2023-11-01
NCT03952572Phase 3Unknown
Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma
Peripheral T-cell Lymphoma
StudychairStart date: 2019-05-10
NCT03797456Phase 2Completed
A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
MZL
PrincipalinvestigatorStart date: 2019-04-01
NCT03494179Phase 1/2Completed
A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)
Mantle Cell Lymphoma
PrincipalinvestigatorStart date: 2018-04-02

Research Network

Collaboration Network

14 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University Cancer Hospital & Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score18%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score18%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score18%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score18%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral
Similarity Score18%

Miguel Ángel Canales Albendea, MD

Hospital La Paz

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score18%

Ting Liu, PhD

West China Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Shanghai CP Guojian Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Yiping Zhang, PhD

Zhejiang Cancer Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Shanghai CP Guojian Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Jifeng Feng, PhD

Jiangsu Cancer Institute & Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Shanghai CP Guojian Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Lugui Qiu, PhD

Tianjin Hematonosis Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Shanghai CP Guojian Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06066203Phase 1/2PrincipalInvestigator

A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

Non-hodgkin's Lymphoma
Recruiting
NCT03952572Phase 3StudyChair

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma
Unknown
NCT03797456Phase 2PrincipalInvestigator

A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)

MZL
Completed
NCT03494179Phase 1/2PrincipalInvestigator

A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)

Mantle Cell Lymphoma
Completed
NCT01459887Phase 3PrincipalInvestigator

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Diffuse Large B Cell Lymphoma
Completed

All 5 trials loaded